-
CARA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Cara Therapeutics (CARA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 38.56 mm | 38.56 mm | 38.56 mm | 38.56 mm | 38.56 mm | 38.56 mm |
Cash burn (monthly) | 4.06 mm | 2.19 mm | 2.00 mm | 7.13 mm | 4.66 mm | 6.19 mm |
Cash used (since last report) | 16.34 mm | 8.79 mm | 8.03 mm | 28.70 mm | 18.76 mm | 24.90 mm |
Cash remaining | 22.23 mm | 29.77 mm | 30.53 mm | 9.87 mm | 19.80 mm | 13.66 mm |
Runway (months of cash) | 5.5 | 13.6 | 15.3 | 1.4 | 4.2 | 2.2 |
13F holders | Current |
---|---|
Total holders | 71 |
Opened positions | 7 |
Closed positions | 19 |
Increased positions | 5 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 4.12 bn |
Total shares | 20.92 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vifor | 7.40 mm | $0.00 |
Vanguard | 2.25 mm | $692.66 mm |
Chescapmanager | 1.70 mm | $524.25 mm |
Farallon Capital Management | 1.56 mm | $479.33 mm |
Disciplined Growth Investors | 1.11 mm | $342.82 mm |
Renaissance Technologies | 1.11 mm | $341.55 mm |
Two Sigma Advisers | 866.30 k | $266.82 mm |
BlackRock | 742.48 k | $228.68 mm |
Millennium Management | 587.91 k | $181.08 mm |
BNP Paribas Arbitrage | 582.54 k | $179.42 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Nov 24 | Posner Christopher | Common Stock | Sell | Dispose S | No | Yes | 0.29 | 3,668 | 1.06 k | 168,768 |
1 Aug 24 | Posner Christopher | Common Stock | Sell | Dispose S | No | Yes | 0.35 | 4,149 | 1.45 k | 172,436 |
4 Jun 24 | Jeffrey L. Ives | Common Stock | Grant | Acquire A | No | No | 0 | 150,647 | 0.00 | 198,485 |
4 Jun 24 | Jeffrey L. Ives | Stock Option Common Stock | Grant | Acquire A | No | No | 0.664 | 195,000 | 129.48 k | 195,000 |
4 Jun 24 | Moltke Lisa von | Common Stock | Grant | Acquire A | No | No | 0 | 150,647 | 0.00 | 183,009 |
4 Jun 24 | Moltke Lisa von | Stock Option Common Stock | Grant | Acquire A | No | No | 0.664 | 195,000 | 129.48 k | 195,000 |
4 Jun 24 | Boudreau Helen M | Common Stock | Grant | Acquire A | No | No | 0 | 150,647 | 0.00 | 150,647 |
4 Jun 24 | Boudreau Helen M | Stock Option Common Stock | Grant | Acquire A | No | No | 0.664 | 195,000 | 129.48 k | 195,000 |